RTW Investments’s Rocket Pharmaceuticals Warrant RCKTW Stock Holding History

RTW Investments’s Portfolio RCKTW Stock Details RCKTW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.19K	Hold	350,000	–	–	﹤0.01%	84
2026 Q1	$7.21K	Hold	350,000	–	–	﹤0.01%	88
2025 Q4	$8.51K	Hold	350,000	–	–	﹤0.01%	91
2025 Q3	$13.7K	Hold	350,000	–	–	﹤0.01%	74
2025 Q2	$10.1K	Hold	350,000	–	–	﹤0.01%	73
2025 Q1	$16.4K	Hold	350,000	–	–	﹤0.01%	68
2024 Q4	$12K	Hold	350,000	–	–	﹤0.01%	72
2024 Q3	$22.6K	Hold	350,000	–	–	﹤0.01%	68
2024 Q2	$21.2K	Hold	350,000	–	–	﹤0.01%	68
2024 Q1	$105K	Hold	350,000	–	–	﹤0.01%	69
2023 Q4	$172K	Hold	350,000	–	–	﹤0.01%	63
2023 Q3	$59.5K	Hold	350,000	–	–	﹤0.01%	67
2023 Q2	$66.5K	Hold	350,000	–	–	﹤0.01%	62
2023 Q1	$38.5K	Buy	+350,000	New	+$67.5K	﹤0.01%	60

Other funds holding RCKTW

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

SCM

Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $5.19B AUM 23.19% 1-Year Est. Return

RTW Investments's RCKTW Position: Q2 2026 in Review

RTW Investments held its Rocket Pharmaceuticals Warrant (RCKTW) position steady in Q2 2026 at 350,000 shares worth $1.19K. The position accounts for ﹤0.01% of the portfolio, ranked #84.

RTW Investments first reported a position in RCKTW in Q1 2023 and has held it in 14 quarters since. The position peaked at $172K in Q4 2023. 11 funds tracked by Wall St. Rank hold RCKTW as of Q2 2026.

RTW Investments held 350,000 shares of Rocket Pharmaceuticals Warrant worth $1.19K as of Q2 2026.
RTW Investments left its Rocket Pharmaceuticals Warrant share count unchanged in Q2 2026.
Rocket Pharmaceuticals Warrant made up ﹤0.01% of RTW Investments's portfolio in Q2 2026, its #84 holding.
RTW Investments first reported a position in Rocket Pharmaceuticals Warrant in Q1 2023 and has held it in 14 quarters since.
RTW Investments's Rocket Pharmaceuticals Warrant position peaked at $172K in Q4 2023.
11 funds tracked by Wall St. Rank held Rocket Pharmaceuticals Warrant as of Q2 2026.

Based on RTW Investments's 13F filing for Q2 2026, filed 14 Aug 2026.